We think that this question is related to ADHD medication as we are emerging from a national shortage of some of the medications required to manage ADHD. This shortage is being overseen by the Department of Health and Social Care and the NHS England’s Medicine’s Supply Team.
We would like to reassure you that the shortages are being monitored weekly within NHS Dorset and a system wide plan involving primary and secondary care clinicians is being developed to allow initiation of therapy for new patients once the national shortage issues have been fully resolved. We would also advise that if you have any questions about your child or young person's individual treatment to seek a view from your health care practitioner.
With regards to waiting times, Dorset has seen a significant and sustained increase in referrals for both ASD and ADHD assessments across all age groups.
This rise reflects a positive shift toward greater awareness and recognition of neurodiversity. At the same time, this has placed unprecedented pressure on services, resulting in long and growing waiting lists.
We, together with our partners have implemented the Partnerships for Inclusion of Neurodiversity in Schools (PINS) pilot, which has recently been extended. This is a national initiative aiming to support the facilitation of early interventions at school level, upskill school staff, and strengthen local partnerships, and ultimately help improve outcomes for neurodivergent children, including those with ASD and ADHD.
In addition, we have completed an All-Age Neurodiversity Review. One of the key outcomes of the review is the launch of our co-produced Dorset Neurodiversity Hub, which is a dedicated website offering local resources, information and support for individuals who are neurodivergent, particularly those with ASD and ADHD, as well as their families and carers. We know that many people have used this new website since it was set up.
Another key recommendation from the review is a shift towards a needs-led model of care, rather than a diagnosis-first approach. Since the review concluded, a Neurodiversity Working Group has been established to guide the development of this model.
A central component of the new model is the development and implementation of the Neurodiversity Exploration and Strengths Tool - Dorset (NEST-D). Building on profiling tools developed initially in Portsmouth and expanded by Cornwall Partnership NHS Foundation Trust, NEST-D aims to support earlier identification of strengths and needs, leading to a personalised support plan. Where appropriate, individuals may then progress for a full diagnostic assessment.
The Neurodiversity Working Group also recognise the need to expand therapeutic interventions beyond medication, ensuring broader, more holistic support. It is anticipated that this new model will include a needs-led, single point of access, improving navigation and accessibility for individuals and families.
If you would like further information about any of this, please drop us an email to [email protected]